File Download
 
 
Supplementary

Conference Paper: Combination of baseline HBV DNA and ALT levels with on-treatment HBV DNA response to select HBeAg-positive patients for lamivudine therapy
  • Basic View
  • Metadata View
  • XML View
TitleCombination of baseline HBV DNA and ALT levels with on-treatment HBV DNA response to select HBeAg-positive patients for lamivudine therapy
 
AuthorsFung, JYY
Lai, CL
Seto, WK
Wong, DKH
Yuen, JCH
Yuen, RMF
 
Issue Date2009
 
Description5th APASL Single Topic Conference (Asian Pacific Association for the Study of the Liver), Istanbul, Turkey
 
DC FieldValue
dc.contributor.authorFung, JYY
 
dc.contributor.authorLai, CL
 
dc.contributor.authorSeto, WK
 
dc.contributor.authorWong, DKH
 
dc.contributor.authorYuen, JCH
 
dc.contributor.authorYuen, RMF
 
dc.date.accessioned2010-07-13T04:00:15Z
 
dc.date.available2010-07-13T04:00:15Z
 
dc.date.issued2009
 
dc.description5th APASL Single Topic Conference (Asian Pacific Association for the Study of the Liver), Istanbul, Turkey
 
dc.identifier.hkuros158501
 
dc.identifier.urihttp://hdl.handle.net/10722/62392
 
dc.languageeng
 
dc.titleCombination of baseline HBV DNA and ALT levels with on-treatment HBV DNA response to select HBeAg-positive patients for lamivudine therapy
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Fung, JYY</contributor.author>
<contributor.author>Lai, CL</contributor.author>
<contributor.author>Seto, WK</contributor.author>
<contributor.author>Wong, DKH</contributor.author>
<contributor.author>Yuen, JCH</contributor.author>
<contributor.author>Yuen, RMF</contributor.author>
<date.accessioned>2010-07-13T04:00:15Z</date.accessioned>
<date.available>2010-07-13T04:00:15Z</date.available>
<date.issued>2009</date.issued>
<identifier.uri>http://hdl.handle.net/10722/62392</identifier.uri>
<description>5th APASL Single Topic Conference (Asian Pacific Association for the Study of the Liver), Istanbul, Turkey</description>
<language>eng</language>
<title>Combination of baseline HBV DNA and ALT levels with on-treatment HBV DNA response to select HBeAg-positive patients for lamivudine therapy</title>
<type>Conference_Paper</type>
<identifier.hkuros>158501</identifier.hkuros>
</item>